Towa Pharmaceutical discloses that its parent company, Yoshida Office Co., Ltd., owns 40.85% of voting rights, and CEO Isao Yoshida also serves as a director of the company. The company states that its operational independence is maintained.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4553","jir_company_name":"Towa Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-06-24","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4553-20260624-04.pdf","jir_short_summary":"Towa Pharmaceutical discloses that its parent company, Yoshida Office Co., Ltd., owns 40.85% of voting rights, and CEO Isao Yoshida also serves as a director of the company. The company states that its operational independence is maintained.","jir_summary":"### Matters Concerning the Controlling Shareholder\nTowa Pharmaceutical discloses that Yoshida Office Co., Ltd. owns 40.85% of voting rights, and CEO Isao Yoshida also serves as a director of the company. Yoshida Office is a related company and states that it does not impact business activities. The company has no transactions with its parent company or affiliates and maintains independence.\n\n### Future Outlook and Impact on Shareholders\nThis document aims to disclose information regarding the controlling shareholder and does not detail specific business performance or future outlook. For investors, it provides important information regarding the ownership ratio of the controlling shareholder and the company's independence.","jir_financial_highlights":"Voting Rights Ownership Ratio (%): 40.85 (Unknown)\nVoting Rights Ownership Ratio of Controlling Shareholder (%): 45.75 (Unknown)","jir_category":"","jir_hashtags":"#TowaPharmaceutical, #IRRelatedCategory, #JapaneseStocks","jir_key_figures":"Voting Rights Ownership Ratio (%): 40.85\nConsolidated Target Portion: 4.90\nVoting Rights Ownership Ratio of Controlling Shareholder (%): 45.75","jir_meta_title":"[Towa Pharmaceutical] Notice Regarding Controlling Shareholder \uff5c June 2026","jir_meta_description":"Towa Pharmaceutical discloses that Yoshida Office Co., Ltd. owns 40.85% of voting rights and CEO Isao Yoshida also serves as a director of the company. The company's independence is maintained.","jir_og_title":"[Towa Pharmaceutical] Controlling Shareholder Information \uff5c June 2026","jir_og_description":"Towa Pharmaceutical discloses information on controlling shareholder ownership ratios and corporate independence. Important information for investment decisions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9026,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-68440","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n